Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
26 studies found for:    "Hepatorenal syndrome"
Show Display Options
Rank Status Study
1 Recruiting Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
Condition: Hepatorenal Syndrome
Interventions: Drug: 5mg Ifetroban Injection;   Drug: 15mg Ifetroban Injection;   Drug: 50mg Ifetroban Injection;   Drug: 150mg Ifetroban Injection;   Other: 5% Dextrose in Water
2 Completed Noradrenalin vs Terlipressin in Hepatorenal Syndrome
Condition: Hepatorenal Syndrome
Interventions: Drug: Terlipressin;   Drug: Noradrenalin
3 Recruiting Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
Condition: Hepatorenal Syndrome
Interventions: Drug: Pentoxyfylline;   Drug: Placebo;   Drug: AMO Therapy
4 Terminated Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
Conditions: Hepatorenal Syndrome;   Renal Failure;   Liver Diseases
Interventions: Procedure: Blood Draws and a hepatectomy specimen;   Procedure: Blood draw - pre operative standard of care
5 Suspended Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
Conditions: Cirrhosis;   Hepatorenal Syndrome
Intervention: Drug: terlipressin
6 Completed Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome
Intervention: Drug: terlipressin
7 Terminated Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
Conditions: Cirrhosis;   Hepatorenal Syndrome
Interventions: Drug: Terlipressin plus albumin;   Drug: Midodrine plus octreotide plus human albumin
8 Recruiting A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
Condition: Hepatorenal Syndrome Type I and Type II
Intervention: Drug: LJPC-501
9 Completed A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Condition: Hepatorenal Syndrome Type 1
Interventions: Drug: Terlipressin;   Drug: Placebo
10 Recruiting Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
Conditions: Cirrhosis;   Type 1 Hepatorenal Syndrome
Interventions: Drug: terlipressin given by intravenous boluses and albumin;   Drug: terlipressin given by continuous intravenous infusion and albumin
11 Completed Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
Condition: Hepatorenal Syndrome
Intervention: Drug: Terlipressin and albumin
12 Recruiting Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
Conditions: Cirrhosis;   Hepatorenal Syndrome Type I
Intervention: Drug: Terlipressin and albumin
13 Completed A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome Type 1
Intervention: Drug: Terlipressin
14 Recruiting To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome'
Condition: Hepatorenal Syndrome
Interventions: Drug: nor adrenaline and terlipressin;   Drug: step up terlipressin therapy
15 Recruiting Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis
Conditions: Acute Kidney Injury;   Hepatorenal Syndrome
16 Recruiting Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury
Conditions: Cirrhosis;   Hepatorenal Syndrome;   Acute Kidney Injury;   Diastolic Function
Intervention: Procedure: Echocardiography
17 Completed Plasma and Hemodynamic Markers During Hepatectomy
Condition: Hepatorenal Syndrome, Liver Regeneration
Intervention: Procedure: Liver resection
18 Completed The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Conditions: Type 2 Hepatorenal Syndrome;   Refractory Ascites
Interventions: Drug: Midodrine, albumin, octreotide LAR;   Drug: midodrine, octreotide, albumin
19 Completed Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
Conditions: Spontaneous Bacterial Peritonitis;   Hepatorenal Syndrome;   Cirrhosis
Intervention: Drug: Oral norfloxacin
20 Unknown  Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
Conditions: Fibrosis;   Renal Failure;   Hepatorenal Syndrome
Interventions: Drug: Albumin;   Drug: Midodrine;   Drug: Octreotide

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years